Toshihiro Aono

No ORCID on file · 9 papers in corpus · active 1978-2001

Study types

  • article 9

Condition tags

  • endometriosis 2
article 2001
Efficacy of Every-Other-Day Administration of Conjugated Equine Estrogen and Medroxyprogesterone Acetate on Gonadotropin-Releasing Hormone Agonists Treatment in Women with Endometriosis
Gynecologic and obstetric investigation ·doi:10.1159/000052978

We performed a randomized controlled study to determine the efficacy of add-backed therapy by every-other-day administration of 0.625 mg conjugated equine estrogen (CEE) and 2.5 mg medroxyprogesterone acetate (MPA) on GnRH agonists (GnRH-a)…

article 1993
Induction of true precocious puberty by neonatal treatment with danazol in female rats
·doi:10.1016/0304-3940(93)90636-y
article 1991
Effects of nocturnal hyperprolactinemia on ovarian luteal function and galactorrhea
·doi:10.1016/0028-2243(91)90056-q
article 1989
Studies on GnRH Agonist Suppression of Estrogen Production in Patients with Endometriosis.
Endocrinologia japonica ·doi:10.1507/endocrj1954.36.611

The chronic administration of GnRH agonists to women results in the reversible suppression of estrogen production by the ovary. In the present study, the mechanism of the GnRH agonist suppression of estrogen production was investigated in p…

article 1987
Growth inhibition by danazol in a human endometrial cancer cell line with estrogen-independent progesterone receptors
·doi:10.1016/0022-4731(87)90517-6
article 1986
Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro
·doi:10.1016/s0002-9378(86)80039-4
article 1985
The effect of lisuride hydrogen maleate on anterior pituitary hormones, oestradiol and cortisol in normal and hyperprolactinaemic women
·doi:10.1016/0028-2243(85)90079-6
article 1983
Absence of effect of danazol on estrogen-induced luteinizing hormone release from rat hypothalamo-pituitary axis in vitro
·doi:10.1016/s0010-7824(83)80009-2
article 1978
Clinical and Endocrinological Analyses of Patients with Galactorrhea and Menstrual Disorders due to Sulpiride or Metoclopramide
·doi:10.1210/jcem-47-3-675

The clinical courses of galactorrhea and menstrual disorders were studied in 18 women with galactorrhea induced by sulpiride (SLP) or metoclopramide (MCP) given for the treatment of gastrointestinal diseases. The response of PRL and TSH to …